Las Vegas, NV -- (SBWIRE) -- 12/20/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Infinity Pharmaceuticals Inc. (NASDAQ:INFI), The AES Corporation (NYSE:AES), Array Biopharma Inc (NASDAQ:ARRY), Transocean LTD (NYSE:RIG)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) managed to keep its gain at 0.88% on below -normal volume of 1.22M shares. The stock settled at $12.61 after floating in a range of $12.42 to $12.89. Its latest price has reached market capitalization of $606.37 million. Its 52-week range has been $11.57 to $50.51. Infinity Pharmaceuticals, Inc. (IPI) is a drug discovery and development company. The Company's lead product is a potent, oral inhibitor of Class I PI3K-delta and PI3K-gamma, which the Company is investigating in both hematologic malignancies and inflammatory diseases.Its retaspimycin hydrochloride (HCl), is a potent and selective inhibitor of heat shock protein 90 (Hsp90).
For How Long INFI will fight for Profitability? Read This Trend Analysis report
The AES Corporation (NYSE:AES) traded down on a volume of 5.85 million, lower than its standard daily volume. Shares have dropped-0.63% to $14.12. Over the last twelve months, the stock has gained 31.47% and faced a worst price of $10.41. The AES Corporation (AES) owns a portfolio of electricity generation and distribution businesses on five continents in 27 countries, with total capacity of approximately 44,200 megawatts and distribution networks. It owns and operates two types of businesses.
Has AES Found The Bottom And Ready To Gain Momentum? Find Out Here
Array Biopharma Inc (NASDAQ:ARRY) settled -1.61% lower at $4.90 on below -normal volume of 1.22M shares during the last trading day. The stock has its 12-month high at $7.10 and 52-week low price was $3.41. It traded in a range of $4.79 to $5.04 during the last trading day. Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases.
Will ARRY Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Transocean LTD (NYSE:RIG) was down on high volume, trading at a volume of 5.82M shares versus its average daily volume of 4.76 million shares. At $47.15, the stock has attained market capitalization of $17 billion. Transocean Ltd. (Transocean) is an international provider of offshore contract drilling services for oil and gas wells. The Company operates in two segments: contract drilling services and drilling management services. Contract drilling services.
Why Should Investors Buy RIG After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)